CME Group sr md, general counsel Marchese sells $203,541 in shares
John Clifford Marchese, Senior Managing Director and General Counsel at CME Group Inc., divested 655 shares of the company's Class A common stock on November 18, 2026, for a total of $203,541. The shares were traded at $310.75 each. Post-sell, Marchese maintained ownership of 2,943 shares of CME Group common stock. This transaction occurred as CME Group's stock hovered near its 52-week peak of $329.16, currently valued at a market cap of $109.64 billion.
According to a Pro Research Report, the stock appears to be overvalued at present. For comprehensive analysis, investors can refer to the full Pro Research Report among 1,400+ available. CME Group's third-quarter 2026 financials showcased strong performance, with adjusted earnings per share at $3.02, exceeding the estimated $2.98.
Revenue reached a record $1.74 billion, marking a 13% year-over-year increase. Market data revenue surged by 20% to $243 million, continuing an impressive 34-quarter streak of growth. Upgrades and price target adjustments from major brokerage firms followed the results. JPMorgan upgraded CME Group's stock rating to Overweight with a $367 price target, while UBS maintained a Neutral rating with a $310 price target.
Additionally, Interactive Brokers launched autonomous trading features supporting over 75,000 global equities, options, and ETFs. AI investments are intensifying in high-frequency trading firms like Jane Street and Hudson River Trading, illustrating sector-wide advancements. This report was AI-generated and editorially reviewed.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.